Could 68Ga-PSMA PET/CT Evaluation Reduce the Number of Scheduled Prostate Biopsies in Men Enrolled in Active Surveillance Protocols?

Background: To evaluate the accuracy of 68Ga-prostate specific membrane antigen (PSMA) PET/CT in the diagnosis of clinically significant prostate cancer (csPCa) (Grade Group > 2) in men enrolled in Active Surveillance (AS) protocol. Methods: From May 2013 to May 2021, 173 men with very low-risk P...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepe, Pietro, Roscigno, Marco, Pepe, Ludovica, Panella, Paolo, Tamburo, Marinella, Marletta, Giulia, Savoca, Francesco, Candiano, Giuseppe, Cosentino, Sebastiano, Ippolito, Massimo, Tsirgiotis, Andreas, Pennisi, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225630/
https://www.ncbi.nlm.nih.gov/pubmed/35743547
http://dx.doi.org/10.3390/jcm11123473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225630/
https://www.ncbi.nlm.nih.gov/pubmed/35743547
http://dx.doi.org/10.3390/jcm11123473

Ejemplares similares